Redefining the association of triglycerides with all-cause and Cardiovascular Disease Mortality in the Chinese population: a nationwide, population-based, prospective cohort study of 3.8 million Chinese adults
Guangyu Li , Linkang He , Xueke Bai , Shi Chen , Hao Dai , Guangda He , Yang Yang , Xiaoyan Zhang , Jianlan Cui , Xi Li , Chris Packard , Jan Boren , Liang Chen , Shengshou Hu
{"title":"Redefining the association of triglycerides with all-cause and Cardiovascular Disease Mortality in the Chinese population: a nationwide, population-based, prospective cohort study of 3.8 million Chinese adults","authors":"Guangyu Li , Linkang He , Xueke Bai , Shi Chen , Hao Dai , Guangda He , Yang Yang , Xiaoyan Zhang , Jianlan Cui , Xi Li , Chris Packard , Jan Boren , Liang Chen , Shengshou Hu","doi":"10.1016/j.lanwpc.2025.101689","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Current international guidelines on dyslipidemia were formulated based on the research performed mostly in White populations. However, whether the association of triglycerides (TGs) with cardiovascular disease (CVD) differs between Chinese and White populations is unknown.</div></div><div><h3>Methods</h3><div>3,789,025 participants from the China Health Evaluation And risk Reduction through nationwide Teamwork (ChinaHEART) were evaluated for the association between TGs and all-cause and CVD mortality with Cox regression models. The findings were tested for sex-specific differences and contrasted with another comparison cohort of 434,919 UK Biobank participants.</div></div><div><h3>Findings</h3><div>92,888 Chinese adults died during a median follow-up of 4.6 years. All-cause and CVD mortality initially increased with TG elevation abruptly and plateaued in Chinese men, while U-shaped associations were seen in Chinese women. In contrast, CVD risk increased incrementally with TGs in White people. Hazard ratios (95% confidence intervals) were 1.02 (0.97–1.07), 1.05 (1.00–1.11), 1.07 (1.02–1.22), and 1.19 (1.13–1.24) from TG quintile 2 to 5 for White men, and 1.14 (1.08–1.21), 1.17 (1.11–1.24), 1.26 (1.18–1.33), and 1.41 (1.33–1.50) for White women, respectively. The association with CVD mortality was stronger in Chinese men who were lean, normotensive, and smoking but in Chinese women with diabetes.</div></div><div><h3>Interpretation</h3><div>The association of TGs with CVD was different for the White and the Chinese populations. That mortality risk elevated in conventionally low-to-moderate TG range implicates that more aggressive intervention may be merited for Chinese and other East Asian populations.</div></div><div><h3>Funding</h3><div>The <span>National High Level Hospital Clinical Research</span> Funding (2023-GSP-ZD-2, 2023-GSP-RC-01), the <span>Ministry of Finance</span>, and the <span>National Health Commission</span> of China.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"63 ","pages":"Article 101689"},"PeriodicalIF":8.1000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Regional Health: Western Pacific","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666606525002287","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Current international guidelines on dyslipidemia were formulated based on the research performed mostly in White populations. However, whether the association of triglycerides (TGs) with cardiovascular disease (CVD) differs between Chinese and White populations is unknown.
Methods
3,789,025 participants from the China Health Evaluation And risk Reduction through nationwide Teamwork (ChinaHEART) were evaluated for the association between TGs and all-cause and CVD mortality with Cox regression models. The findings were tested for sex-specific differences and contrasted with another comparison cohort of 434,919 UK Biobank participants.
Findings
92,888 Chinese adults died during a median follow-up of 4.6 years. All-cause and CVD mortality initially increased with TG elevation abruptly and plateaued in Chinese men, while U-shaped associations were seen in Chinese women. In contrast, CVD risk increased incrementally with TGs in White people. Hazard ratios (95% confidence intervals) were 1.02 (0.97–1.07), 1.05 (1.00–1.11), 1.07 (1.02–1.22), and 1.19 (1.13–1.24) from TG quintile 2 to 5 for White men, and 1.14 (1.08–1.21), 1.17 (1.11–1.24), 1.26 (1.18–1.33), and 1.41 (1.33–1.50) for White women, respectively. The association with CVD mortality was stronger in Chinese men who were lean, normotensive, and smoking but in Chinese women with diabetes.
Interpretation
The association of TGs with CVD was different for the White and the Chinese populations. That mortality risk elevated in conventionally low-to-moderate TG range implicates that more aggressive intervention may be merited for Chinese and other East Asian populations.
Funding
The National High Level Hospital Clinical Research Funding (2023-GSP-ZD-2, 2023-GSP-RC-01), the Ministry of Finance, and the National Health Commission of China.
期刊介绍:
The Lancet Regional Health – Western Pacific, a gold open access journal, is an integral part of The Lancet's global initiative advocating for healthcare quality and access worldwide. It aims to advance clinical practice and health policy in the Western Pacific region, contributing to enhanced health outcomes. The journal publishes high-quality original research shedding light on clinical practice and health policy in the region. It also includes reviews, commentaries, and opinion pieces covering diverse regional health topics, such as infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, aging health, mental health, the health workforce and systems, and health policy.